Toggle navigation
Home
Search
Services
Blog
Contact
About
Probes to Detect Ebv Integration in Human Cells
Lewis, Marcia
Genaissance Pharmaceuticals, Inc., New Haven, CT, United States
Search 3 grants from Marcia Lewis
Search grants from Genaissance Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of a Multimodal Deep Learning Model for the Generation of Cancer Probability Maps and Imaging Biomarkers for Prostate Cancer using Multiparametric MRI
The Outer Surface of Vibrio cholerae
Membership in the Massachusetts Institute of Technology
Molecular Genetics of Drosophila Development & Behavior
Kinetic Studies of the Blood
Recently added grants:
Statistical Methods in Trans-Omics Chronic Disease Research
A Novel Proteolytic System of Pulmonary Inflammation
Identification of the role of HDL function in human cardiovascular disease through proteomics and genetics
Respect for Persons in the Genomics Research Enrollment Process: Incorporating Diverse Experiences and Attitudes
Neurovascular Regulation During Exercise In Humans With Chronic Kidney Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CP095631-000
Application #
3635125
Study Section
Project Start
1989-05-16
Project End
Budget Start
1989-05-16
Budget End
1989-11-15
Support Year
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Genaissance Pharmaceuticals, Inc.
Department
Type
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06511
Related projects
NIH 1990
N43 CP
Probes to Detect Ebv Integration in Human Cells
Lewis, Marcia / Genaissance Pharmaceuticals, Inc.
NIH 1989
N43 CP
Probes to Detect Ebv Integration in Human Cells
Lewis, Marcia / Genaissance Pharmaceuticals, Inc.
Comments
Be the first to comment on Marcia Lewis's grant